Access to Guideline-Directed Heart Failure Therapy in Brazil: Methodological and Policy Considerations
International Journal of Cardiovascular Sciences · 08.07.2026 · 39
DOI: 10.36660/ijcs.20260067 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Cardiovascular Sciences, erschienen am 08.07.2026. Verfasst von Fatih Aydin. Die Arbeit nennt 10 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
While the study’s findings are valuable, some methodological aspects could affect how we interpret them. The analysis is based solely on the presence of medications in Municipal Lists of Essential Medicines (REMUMEs), rather than on actual dispensing records or pharmacy inventory data. However, the fact that a medication is on an official list does not mean that patients can actually receive it in practice. Local procurement rules, supply chain issues, and prescribing practices can significantly affect the availability of drugs [...]
Zitieren
APA
Aydin, F. (2026). Access to Guideline-Directed Heart Failure Therapy in Brazil: Methodological and Policy Considerations. International Journal of Cardiovascular Sciences, 39. https://doi.org/10.36660/ijcs.20260067
Vancouver
Aydin F. Access to Guideline-Directed Heart Failure Therapy in Brazil: Methodological and Policy Considerations. International Journal of Cardiovascular Sciences. 2026;39. doi:10.36660/ijcs.20260067
BibTeX
@article{Aydin2026,
author = {Aydin, Fatih},
title = {Access to Guideline-Directed Heart Failure Therapy in Brazil: Methodological and Policy Considerations},
journal = {International Journal of Cardiovascular Sciences},
year = {2026},
volume = {39},
doi = {10.36660/ijcs.20260067}
}
EUVIMED